BioWorld-Insight-2011-03-14

No Abstract

No Abstract

No Abstract

No Abstract

No Abstract

After a 56-year dearth, the FDA has finally signed off on a new medication for lupus. Last week, the agency approved Human Genome Sciences Inc.'s and partner GlaxoSmithKline plc's Benlysta (belimumab) for treating systemic lupus erythematosus (SLE). (See Bioworld Today, Mar. 11, 2011.)

No Abstract

No Abstract

No Abstract

No Abstract